Redox-based therapeutics in neurodegenerative disease. - Wikidata - awgldk - TriplyDB

Redox-based therapeutics in neurodegenerative disease.

Redox-based therapeutics in neurodegenerative disease.

http://www.wikidata.org/entity/Q34535918

about

Resveratrol modulates GSH system in C6 astroglial cells through heme oxygenase 1 pathway.Evaluation of the Antioxidant Activity of the Marine Pyrroloiminoquinone Makaluvamines.The Emerging Role of GLP-1 Receptors in DNA Repair: Implications in Neurological Disorders.The Evaluation of Oxidative Stress Parameters in Serum Patients with Relapsing-Remitting Multiple Sclerosis Treated with II-Line Immunomodulatory Therapy.Oxidative stress and its possible relation to lower urinary tract functional pathology.Evaluation of the Protective Effects of Sarains on H2O2-Induced Mitochondrial Dysfunction and Oxidative Stress in SH-SY5Y Neuroblastoma Cells.Salidroside Protects against MPP+-Induced Neuronal Injury through DJ-1-Nrf2 Antioxidant Pathway.n-butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD1G93A mouse model of amyotrophic lateral sclerosis.

P2860

Q38722142-7254C9E9-0C0F-4718-9335-07878522E654 Q38734585-5FB79640-9594-4313-B05D-31A0D785482A Q41661210-22034E2E-6202-4D80-8EF2-FDF5E4B31645 Q43375909-DE4DF965-4B7F-45B2-90C7-2514CD084F09 Q46276286-7A6B1452-8EB3-4886-9451-2175E982F65B Q46370532-3DAF84A7-89F3-4A60-A306-7CAF7AADAF4D Q46677370-94807CF4-6CE0-401E-BAC2-F332586D2076 Q48204504-5E3411BA-D6FD-4476-B87F-EA1AC0B44181

P2860

Redox-based therapeutics in neurodegenerative disease.

http://www.wikidata.org/entity/Q34535918

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Redox-based therapeutics in neurodegenerative disease.

@ast

Redox-based therapeutics in neurodegenerative disease.

@en

Redox-based therapeutics in neurodegenerative disease.

@nl

type

label

Redox-based therapeutics in neurodegenerative disease.

@ast

Redox-based therapeutics in neurodegenerative disease.

@en

Redox-based therapeutics in neurodegenerative disease.

@nl

prefLabel

Redox-based therapeutics in neurodegenerative disease.

@ast

Redox-based therapeutics in neurodegenerative disease.

@en

Redox-based therapeutics in neurodegenerative disease.

@nl

P1433

Q34535918-11DB00D7-2AEB-4A8F-8D31-2E80FA85F4A9

P1476

Q34535918-6910ECDE-4CA1-4BA2-97D2-13935D483EA6

P2093

Q34535918-7F6EA29E-F06C-407D-866A-232884A57336

Q34535918-DA12284D-0F8D-46E9-8605-1E01104D523D

P2860

Q34535918-0075444A-A838-4E39-9694-2CE386AC8BB8

Q34535918-02F16F2C-52BB-4676-8EFC-DC1B27CF7615

Q34535918-038B20E6-E2E8-4636-B990-454F956D4299

Q34535918-059B8DAA-C286-41B7-96F3-904E55247C58

Q34535918-07BF3A41-8C2D-48FC-8962-EFB50D5DC2A1

Q34535918-0A49EC12-A8E3-4CBF-B0CD-15EAF942EEBA

Q34535918-0B38321A-A2B7-402E-A8AE-3F5B98E43C94

Q34535918-0B6AD2EC-C340-4EDF-9057-C61B9D9BE8A3

Q34535918-0FCD7A76-26CC-4C32-98B1-FEFFD4886718

Q34535918-0FEC21FD-2FAE-49AE-9B1C-BD139A3D60C4

P304

Q34535918-AB19FEDC-6A64-486F-AF6E-4C9837B3BA38

P31

Q34535918-5980B9D7-5DC0-4CF0-A65D-184944A734D8

P356

Q34535918-E2FEBDFA-23AE-4EAC-BCE4-D078AD1CDBDB

P407

Q34535918-D453A906-8211-4A1B-8096-F7DCBCE700BE

P433

Q34535918-E68A4833-290D-4480-B047-A6A3C941BC78

P478

Q34535918-5782A15F-CC00-4363-A828-FF638F6DD8DD

P50

Q34535918-FD55946E-751B-49CB-B6CF-285606C36380

P577

Q34535918-E0E92DB7-AE61-490A-A62B-7424D9C826A5

P698

Q34535918-7600C2A5-4206-4CBD-9FF0-EAD80713BFA6

P921

Q34535918-9E90051B-17FD-401B-AAAF-479858D3CB13

P932

Q34535918-2CCAF9F3-2935-43C3-B392-91F319F432C7

P356

P1433

British Journal of Pharmacology

P1476

Redox-based therapeutics in neurodegenerative disease.

@en

P2093

G J McBean

http://www.w3.org/2001/XMLSchema#string

M G López

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins

Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2

Dimethyl fumarate for multiple sclerosis

Ascorbic acid for the treatment of Charcot-Marie-Tooth disease

Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element

Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2

Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival

Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease

Mitochondrial Dysfunction in Alzheimer's Disease and the Rationale for Bioenergetics Based Therapies

Curcumin and Health

P304

1750-1770

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BPH.13551

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

174

http://www.w3.org/2001/XMLSchema#string

P50

Fredrik K. Wallner

P577

2016-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27477685

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

5446580

http://www.w3.org/2001/XMLSchema#string